世界の組換えタンパク質治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Recombinant Protein Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4959 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、組換えタンパク質治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（組換えホルモン、インターフェロン、インターロイキン、造血成長因子、その他）、用途別市場規模（糖尿病、小人症、心臓病、がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・組換えタンパク質治療薬の市場動向 ・企業の競争状況、市場シェア ・組換えタンパク質治療薬の種類別市場規模（組換えホルモン、インターフェロン、インターロイキン、造血成長因子、その他） ・組換えタンパク質治療薬の用途別市場規模（糖尿病、小人症、心臓病、がん、その他） ・組換えタンパク質治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・組換えタンパク質治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・組換えタンパク質治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・組換えタンパク質治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・組換えタンパク質治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Pfizer、Merck、Roche、Biogen、Bayer、J&J、Amgen、Sanofi、Ligand） ・結論

In the 1970s, recombinant DNA technology hardly opened a new era of pharmaceutical biotechnology. Therefore, the definition of protein therapeutics covers drugs that are structurally proteins or peptides, as well as drugs obtained through recombinant DNA technology.

Market Analysis and Insights: Global Recombinant Protein Therapeutics Market
The global Recombinant Protein Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Protein Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Protein Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Protein Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Protein Therapeutics market.

Global Recombinant Protein Therapeutics Scope and Market Size
Recombinant Protein Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Protein Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Recombinant Hormones
Interferons
Interleukins
Hematopoietic Growth Factors
Others

Segment by Application
Diabetes
Dwarfism
Heart Disease
Cancer
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Pfizer
Merck
Roche
Biogen
Bayer
J&J
Amgen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Recombinant Hormones
1.2.3 Interferons
1.2.4 Interleukins
1.2.5 Hematopoietic Growth Factors
1.2.6 Others
1.3 Market by Application
1.3.1 Global Recombinant Protein Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diabetes
1.3.3 Dwarfism
1.3.4 Heart Disease
1.3.5 Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Recombinant Protein Therapeutics Market Perspective (2016-2027)
2.2 Recombinant Protein Therapeutics Growth Trends by Regions
2.2.1 Recombinant Protein Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant Protein Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant Protein Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant Protein Therapeutics Industry Dynamic
2.3.1 Recombinant Protein Therapeutics Market Trends
2.3.2 Recombinant Protein Therapeutics Market Drivers
2.3.3 Recombinant Protein Therapeutics Market Challenges
2.3.4 Recombinant Protein Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Therapeutics Players by Revenue
3.1.1 Global Top Recombinant Protein Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Recombinant Protein Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant Protein Therapeutics Revenue
3.4 Global Recombinant Protein Therapeutics Market Concentration Ratio
3.4.1 Global Recombinant Protein Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Therapeutics Revenue in 2020
3.5 Recombinant Protein Therapeutics Key Players Head office and Area Served
3.6 Key Players Recombinant Protein Therapeutics Product Solution and Service
3.7 Date of Enter into Recombinant Protein Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Protein Therapeutics Breakdown Data by Type
4.1 Global Recombinant Protein Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Recombinant Protein Therapeutics Forecasted Market Size by Type (2022-2027)

5 Recombinant Protein Therapeutics Breakdown Data by Application
5.1 Global Recombinant Protein Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Recombinant Protein Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Recombinant Protein Therapeutics Market Size (2016-2027)
6.2 North America Recombinant Protein Therapeutics Market Size by Type
6.2.1 North America Recombinant Protein Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Recombinant Protein Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Recombinant Protein Therapeutics Market Size by Type (2016-2027)
6.3 North America Recombinant Protein Therapeutics Market Size by Application
6.3.1 North America Recombinant Protein Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Recombinant Protein Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Recombinant Protein Therapeutics Market Size by Application (2016-2027)
6.4 North America Recombinant Protein Therapeutics Market Size by Country
6.4.1 North America Recombinant Protein Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Recombinant Protein Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Recombinant Protein Therapeutics Market Size (2016-2027)
7.2 Europe Recombinant Protein Therapeutics Market Size by Type
7.2.1 Europe Recombinant Protein Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Recombinant Protein Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Recombinant Protein Therapeutics Market Size by Type (2016-2027)
7.3 Europe Recombinant Protein Therapeutics Market Size by Application
7.3.1 Europe Recombinant Protein Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Recombinant Protein Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Recombinant Protein Therapeutics Market Size by Application (2016-2027)
7.4 Europe Recombinant Protein Therapeutics Market Size by Country
7.4.1 Europe Recombinant Protein Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Recombinant Protein Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Recombinant Protein Therapeutics Market Size by Type
8.2.1 Asia-Pacific Recombinant Protein Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant Protein Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant Protein Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant Protein Therapeutics Market Size by Application
8.3.1 Asia-Pacific Recombinant Protein Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant Protein Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant Protein Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant Protein Therapeutics Market Size by Region
8.4.1 Asia-Pacific Recombinant Protein Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant Protein Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Recombinant Protein Therapeutics Market Size (2016-2027)
9.2 Latin America Recombinant Protein Therapeutics Market Size by Type
9.2.1 Latin America Recombinant Protein Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant Protein Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant Protein Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Recombinant Protein Therapeutics Market Size by Application
9.3.1 Latin America Recombinant Protein Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant Protein Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant Protein Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Recombinant Protein Therapeutics Market Size by Country
9.4.1 Latin America Recombinant Protein Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant Protein Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Recombinant Protein Therapeutics Market Size by Type
10.2.1 Middle East & Africa Recombinant Protein Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant Protein Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant Protein Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant Protein Therapeutics Market Size by Application
10.3.1 Middle East & Africa Recombinant Protein Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant Protein Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant Protein Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant Protein Therapeutics Market Size by Country
10.4.1 Middle East & Africa Recombinant Protein Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant Protein Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Recombinant Protein Therapeutics Introduction
11.1.4 Eli Lilly Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Recombinant Protein Therapeutics Introduction
11.2.4 Pfizer Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Recombinant Protein Therapeutics Introduction
11.3.4 Merck Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Recombinant Protein Therapeutics Introduction
11.4.4 Roche Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Biogen
11.5.1 Biogen Company Details
11.5.2 Biogen Business Overview
11.5.3 Biogen Recombinant Protein Therapeutics Introduction
11.5.4 Biogen Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.5.5 Biogen Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Recombinant Protein Therapeutics Introduction
11.6.4 Bayer Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 J&J
11.7.1 J&J Company Details
11.7.2 J&J Business Overview
11.7.3 J&J Recombinant Protein Therapeutics Introduction
11.7.4 J&J Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.7.5 J&J Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Recombinant Protein Therapeutics Introduction
11.8.4 Amgen Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Recombinant Protein Therapeutics Introduction
11.9.4 Sanofi Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Ligand
11.10.1 Ligand Company Details
11.10.2 Ligand Business Overview
11.10.3 Ligand Recombinant Protein Therapeutics Introduction
11.10.4 Ligand Revenue in Recombinant Protein Therapeutics Business (2016-2021)
11.10.5 Ligand Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Recombinant Protein Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Recombinant Hormones
Table 3. Key Players of Interferons
Table 4. Key Players of Interleukins
Table 5. Key Players of Hematopoietic Growth Factors
Table 6. Key Players of Others
Table 7. Global Recombinant Protein Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Recombinant Protein Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Recombinant Protein Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Recombinant Protein Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Recombinant Protein Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Recombinant Protein Therapeutics Market Share by Regions (2022-2027)
Table 13. Recombinant Protein Therapeutics Market Trends
Table 14. Recombinant Protein Therapeutics Market Drivers
Table 15. Recombinant Protein Therapeutics Market Challenges
Table 16. Recombinant Protein Therapeutics Market Restraints
Table 17. Global Recombinant Protein Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Recombinant Protein Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Recombinant Protein Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Protein Therapeutics as of 2020)
Table 20. Ranking of Global Top Recombinant Protein Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Recombinant Protein Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Recombinant Protein Therapeutics Product Solution and Service
Table 24. Date of Enter into Recombinant Protein Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Recombinant Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Recombinant Protein Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Recombinant Protein Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Recombinant Protein Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Recombinant Protein Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Recombinant Protein Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Recombinant Protein Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Recombinant Protein Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Recombinant Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Recombinant Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Recombinant Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Recombinant Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Recombinant Protein Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Recombinant Protein Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Recombinant Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Recombinant Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Recombinant Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Recombinant Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Recombinant Protein Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Recombinant Protein Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Recombinant Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Recombinant Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Recombinant Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Recombinant Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Recombinant Protein Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Recombinant Protein Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Recombinant Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Recombinant Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Recombinant Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Recombinant Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Recombinant Protein Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Recombinant Protein Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Recombinant Protein Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Recombinant Protein Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Recombinant Protein Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Recombinant Protein Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Recombinant Protein Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Recombinant Protein Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Eli Lilly Company Details
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Recombinant Protein Therapeutics Product
Table 67. Eli Lilly Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Recombinant Protein Therapeutics Product
Table 72. Pfizer Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Recombinant Protein Therapeutics Product
Table 77. Merck Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Recombinant Protein Therapeutics Product
Table 82. Roche Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Roche Recent Development
Table 84. Biogen Company Details
Table 85. Biogen Business Overview
Table 86. Biogen Recombinant Protein Therapeutics Product
Table 87. Biogen Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Biogen Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Recombinant Protein Therapeutics Product
Table 92. Bayer Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. J&J Company Details
Table 95. J&J Business Overview
Table 96. J&J Recombinant Protein Therapeutics Product
Table 97. J&J Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 98. J&J Recent Development
Table 99. Amgen Company Details
Table 100. Amgen Business Overview
Table 101. Amgen Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Amgen Recent Development
Table 103. Sanofi Company Details
Table 104. Sanofi Business Overview
Table 105. Sanofi Recombinant Protein Therapeutics Product
Table 106. Sanofi Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Ligand Company Details
Table 109. Ligand Business Overview
Table 110. Ligand Recombinant Protein Therapeutics Product
Table 111. Ligand Revenue in Recombinant Protein Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Ligand Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Protein Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Recombinant Hormones Features
Figure 3. Interferons Features
Figure 4. Interleukins Features
Figure 5. Hematopoietic Growth Factors Features
Figure 6. Others Features
Figure 7. Global Recombinant Protein Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Diabetes Case Studies
Figure 9. Dwarfism Case Studies
Figure 10. Heart Disease Case Studies
Figure 11. Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Recombinant Protein Therapeutics Report Years Considered
Figure 14. Global Recombinant Protein Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Recombinant Protein Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Recombinant Protein Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Recombinant Protein Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Recombinant Protein Therapeutics Market Share by Players in 2020
Figure 19. Global Top Recombinant Protein Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Protein Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Recombinant Protein Therapeutics Revenue in 2020
Figure 21. Global Recombinant Protein Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Recombinant Protein Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Recombinant Protein Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Recombinant Protein Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Recombinant Protein Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Recombinant Protein Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Recombinant Protein Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Recombinant Protein Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Recombinant Protein Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Recombinant Protein Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Recombinant Protein Therapeutics Market Share by Region (2016-2027)
Figure 43. China Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Recombinant Protein Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Recombinant Protein Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Recombinant Protein Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Recombinant Protein Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Recombinant Protein Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Recombinant Protein Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Recombinant Protein Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Eli Lilly Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 66. Biogen Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 68. J&J Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 71. Ligand Revenue Growth Rate in Recombinant Protein Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---